ArticleThe Journal of clinical investigation2016

Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus.

Jianxun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.